{
    "title": "Eli Lilly says FDA could deny expanded use of arthritis drug for eczema",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10452395/Eli-Lilly-expects-FDA-deny-expanded-use-arthritis-drug-eczema.html",
    "date": "2022-01-28",
    "keywords": [
        "drug",
        "use",
        "approval",
        "fda",
        "covid19",
        "company",
        "rinvoq",
        "olumiant",
        "jan",
        "friday",
        "food",
        "administration",
        "treatment",
        "eczema",
        "point",
        "alignment",
        "population",
        "drugmaker",
        "incyte",
        "corp",
        "class",
        "jak",
        "scrutiny",
        "xeljanz",
        "risk",
        "cancer",
        "trial",
        "path",
        "review",
        "timeline",
        "httpsinvestorlillycomnewsreleasesnewsreleasedetailslillyandincyteprovideupdatesupplementalnewdrug",
        "month",
        "product",
        "subset",
        "cibinqo",
        "analyst",
        "vamil",
        "divan",
        "client",
        "note",
        "program",
        "disease",
        "lupus",
        "latestage",
        "decision",
        "alopecia",
        "type",
        "hair",
        "loss",
        "emergency",
        "oxygen",
        "ventilation",
        "action",
        "quarter",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}